Teladoc Health Inc.
TDOC | NYSE
$6.22
-$0.05 (-0.80%)
Sep 22, 2026, 11:51 AM ET · Market open
Company Profile
Teladoc Health, Inc. offers remote medical services to individuals both domestically in the United States and internationally. Their extensive range of solutions covers a wide array of health needs, from routine and acute conditions to complex and long-term illnesses such as diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and various mental health issues. The company delivers numerous programs, including virtual primary and specialized medical care, management for chronic diseases, expert second opinion services, mental wellness support, and core platform and service offerings. They serve a diverse client base, including corporations, health insurance providers, hospitals and healthcare systems, financial service companies, and individual patients. The Teladoc, Livongo, and BetterHelp brands fall under their purview. Founded in 2002, the company, which operated as Teladoc, Inc. until its renaming in August 2018, is based in Purchase, New York.
Key Executives
| Name | Position |
|---|---|
| Charles Divita | CEO, Interim Principal Financial Officer & Director |
| Adam Christian Vandervoort | Chief Legal Officer & Secretary |
| Dave Ross | Chief Technology Officer |
| Carlos Nueno | President of International |
| Fernando Madeira | President of BetterHelp |
| George Byron Brooks | Co-Founder |
| Joseph Ronald Catapano Cpa | Senior Vice President & Chief Accounting Officer |
| Kelly Bliss | President of U.S. Group Health |
| Laura Whipple | Chief Communications & Brand Officer |
| Michael Minchak | Vice President of Investor Relations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 03, 2026 | 4 | Filing |
| Sep 03, 2026 | 4 | Filing |
| Sep 03, 2026 | 4 | Filing |
| Sep 03, 2026 | 4 | Filing |
| Sep 03, 2026 | 4 | Filing |
| Sep 03, 2026 | 4 | Filing |
| Sep 01, 2026 | 4 | Filing |
| Sep 01, 2026 | 3 | Filing |
| Aug 31, 2026 | 8-K | Current Report |
| Aug 13, 2026 | 8-K | Current Report |
Teladoc Health Inc.
| Country | United States |
| IPO Date | Jun 29, 2015 |
| Industry | Medical - Healthcare Information Services |
| Sector | Healthcare |
| Employees | 5,124 |
| CEO | Charles Divita |
Contact Details
155 E 44th Street New York,
New York 10017 United States
Stock Details
| Ticker Symbol | TDOC |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001477449 |
| CUSIP Number | 87918A105 |
| ISIN Number | US87918A1051 |
| SIC Code | 8011 |
Recent News
- 4 days ago / zacks.comTeladoc (TDOC) Stock Slides as Market Rises: Facts to Know Before You Trade
- 11 days ago / zacks.comWhy Teladoc (TDOC) Outpaced the Stock Market Today
- 14 days ago / fool.com2 Beaten-Down Stocks to Avoid Right Now
- 15 days ago / zacks.comHere's Why Teladoc's Integrated Care Business Deserves More Attention
- 19 days ago / globenewswire.comTeladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08
- 20 days ago / zacks.comHere's Why Investors Should Stay Neutral on TDOC Stock for Now
- 22 days ago / reuters.comTeladoc appoints insurance executive Michael Grasher as CFO
- 22 days ago / globenewswire.comTeladoc Health Appoints Michael Grasher as Chief Financial Officer
- 25 days ago / zacks.comTeladoc (TDOC) Down 3.3% Since Last Earnings Report: Can It Rebound?
- 26 days ago / prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc. - TDOC
Add to Watchlist
Select watchlists to add or remove TDOC